(Q36653970)

15 August 2017

1 reference

title

Links between nutrition, drug abuse, and the metabolic syndrome (English)

1 reference

15 August 2017

1 reference

1 reference

Ashraf Virmani

1

1 reference

15 August 2017

Zbigniew Binienda

series ordinal

2

1 reference

15 August 2017

Syed Ali

series ordinal

3

1 reference

15 August 2017

Franco Gaetani

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Annals of the New York Academy of Sciences

15 August 2017

published in

1 reference

15 August 2017

volume

1074

1 reference

15 August 2017

page(s)

303-314

1 reference

Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Mechanisms of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Nutritional assessment of drug addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Serum vitamin E, C and A status of the drug addicts undergoing detoxification: influence of drug habit, sexual practice and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Diet influences cocaine withdrawal behaviors in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Street drug use among young patients with Type 1 diabetes in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Diabetic ketoacidosis associated with cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Alcohol and drug use in teenagers with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Genes and gene expression in the brain of the alcoholic

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Expression of MBP, PLP, MAG, CNP, and GFAP in the Human Alcoholic Brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Role of mitochondrial dysfunction and oxidative stress in the pathogenesis of selective neuronal loss in Wernicke's encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Role of carnitine esters in brain neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Selenium, oxidative stress, and health aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Bioenergetic approaches for neuroprotection in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Relating structure to mechanism in creatine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Metabolic issues in patients with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Tobacco smoke exposure is associated with the metabolic syndrome in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

Nutrition education is positively associated with substance abuse treatment program outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1369.027

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1369.027

1 reference

15 August 2017

1 reference